In Brief: Endosonics
This article was originally published in The Gray Sheet
Executive Summary
Endosonics: Intravascular ultrasound products manufacturer plans to commence shipments this month of its WaveWire/WaveMap angioplasty guidewire system, which was cleared in September for use in measuring intracoronary blood pressure ("The Gray Sheet" Sept. 15, In Brief). The device will be marketed through a combination of Endosonics' 32-person direct sales force and Johnson & Johnson's Cordis unit, which is the primary worldwide distributor of the product. One-third of WaveWire/WaveMap sales outside the U.S. currently are generated by direct sales and non-Cordis distributors, Endosonics says...